GE HealthCare Technologies
86,24$
+0,29 (+0,34%)
26.04.2024, 23:29:28 Uhr
WKN: A3D3G6 ISIN: US36266G1076 Wertpapiertyp: Aktie Währung: US-Dollar
- 1T
- 1W
- 1M
- 3M
- 6M
- 1J
- 3J
- 5J
- 10J
- Max
Weltmärkte
- DAX ® +243,73 +1,36% 18.161,01
- MDAX ® +132,30 +0,51% 26.175,48
- TecDAX ® +55,73 +1,71% 3.322,49
- E-STOXX 50 ® +67,84 +1,37% 5.006,85
- NASDAQ 100 +287,79 +1,65% 17.718,30
- NIKKEI +620,41 +1,64% 38.345,55
- HANG SENG +391,28 +2,26% 17.651,15
Kursperformance
Zeitraum | Kurs | % |
---|---|---|
1 Tag | 85,95$ | +0,34% |
1 Woche | 84,40$ | +1,83% |
1 Monat | 88,90$ | -3,32% |
6 Monate | 64,05$ | +34,20% |
Lfd. Jahr (YTD) | 76,60$ | +12,21% |
1 Jahr | 86,84$ | -1,03% |
3 Jahre | -- | -- |
5 Jahre | -- | -- |
Kursdaten
Kurs | 86,24$ |
Schluss Vortag | 85,95$ |
Eröffnung | 85,36$ |
Geld | 86,01$ |
Brief | 86,75$ |
Tages-Hoch | 86,90$ |
Tages-Tief | 85,16$ |
52 Wochen-Hoch | 94,50$ |
52 Wochen-Tief | 62,35$ |
Allzeit-Hoch | 94,50$ |
Allzeit-Tief | 53,50$ |
Nachrichten
- BUSINESS WIRE: GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies - 02.11.2023, 13:00:09 Uhr
- BUSINESS WIRE: SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers - 11.10.2023, 14:00:54 Uhr
- BUSINESS WIRE: First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies - 15.06.2023, 08:00:06 Uhr
- BUSINESS WIRE: GE HealthCare Expands Contrast Media Portfolio with Launch of MRI Agent Pixxoscan (gadobutrol) - 27.04.2023, 08:00:06 Uhr